Athersys logo
Athersys ATHX
report update icon

Quarterly report 2023-Q3
added 06-27-2026

Athersys DSO Ratio | ATHX

Annual DSO Ratio Athersys

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
73 46.8 22.6 8.49 6.37 58.3 10.1 16.1 137 75.6 24.7 53.2 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
137 6.37 44.3

Quarterly DSO Ratio Athersys

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - 421 11.8 - - - - - - - - - - - - 8.27 25.2 22 3.07 57.6 50.4 150 162 73.4 41.6 139 104 3.15 2.91 311 1.1 K 220 264 215 189 91.2 48.2 75.6 83.8 135 18.5 51.3 18.9 18.1 15.4 11.7 20.9 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.1 K 2.91 123

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
Brickell Biotech Brickell Biotech
BBI
26 - -5.38 % $ 6.06 M usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
47.6 - - $ 344 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
107 - - $ 25.3 M usaUSA
Merus N.V. Merus N.V.
MRUS
18.6 - - $ 5.78 B niderlandNiderland
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
Galapagos NV Galapagos NV
GLPG
56.5 - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
178 - -4.36 % $ 27 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
33.4 $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
36.8 $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
17.8 - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
13.6 - - $ 35.3 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
75.3 - 0.52 % $ 821 M danmarkDanmark
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
21.2 - -0.04 % $ 2.62 B usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
158 - -23.04 % $ 26.6 M usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
136 - - $ 69.7 B britainBritain
Guardion Health Sciences Guardion Health Sciences
GHSI
62.6 - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
84.9 - - $ 109 M usaUSA
ImmunoGen ImmunoGen
IMGN
121 - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
114 - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
2.26 K - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
740 - - $ 591 K irlandaIrlanda
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
260 - -2.99 % $ 2.47 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
115 - -4.8 % $ 255 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
14.7 - -0.23 % $ 916 M usaUSA
bluebird bio bluebird bio
BLUE
0.653 - - $ 546 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
96.4 - - $ 35.4 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
31.4 - - $ 728 M usaUSA